08:30 - 10:00 CHRONIC VIRAL HEPATITIS
  Moderator: Osamu Yokosuka, Wasim Jafri, Hikmet Akkız
08:30 - 08:50 Alcohol Use and Other Factors Contributing to Disease Progression and Non-Response to Therapy
Gyongi Zsabo
08:50 - 09:10 Antiviral Immunity in Chronic Viral Hepatitis
Gyongi Zsabo
09:10 - 09:30 Prediction and Diagnosis of Non-Response
Simten Malhan
09:30 - 09:50 Epidemiology and Burden of Non-Response in the World
Simten Malhan
09:50 - 10:00 Discussion
10.00 - 10.30 COFFEE BREAK
10.30 - 12.00 CHRONIC HEPATITIS B
  Moderators: Abdullah Sonsuz, Yücel Üstündağ, Alper Yurci
10:30 - 10:50 Natural Courses of HBV Infection
Osman Cavit Özdoğan
10:50 - 11:10 Current Management of Chronic HBV Infection
Zaigham Abbas
11:10 - 11:30 New Horizons for the Treatment of Chronic Hepatitis B
Tarık Asselah
11:30 - 11:50 The Treatment of HBe Ag Non-Seroconverter on Long Term Anti Viral Therapy  
Saeed Hamid
11:50 - 12:00 Discussion
12.00 - 13.00  Opening Ceremony
13.00 - 14.00 LUNCH
14:00 - 15:30  CHRONIC HEPATITIS D
  Moderators: Mario Rizetto, Halil Değertekin, Gülnara Ageyava
14:00 - 14:20 Retreatment with Interferon in Non Responders
Fulya Günşar
14:20 - 14:40 Longer Treatment with Interferon as an Option
Bülent Değertekin       
14:40 - 15:00 The Treatment of Co-Infection with Delta
Kendal Yalçın
15:00 - 15:20 New Treatment Modalities in Non-Responders
Mario Rizetto          
15:20 - 15:30 Discussion
15:30 - 16:00 COFFEE BREAK
16.00 - 17.30 SPECIAL POPULATIONS  IN CHB  
  Moderator: Tarık Asselah, M. Hadi Yaşa, Hürrem Bodur
16:00 - 16:20 Pregnancy and Lactation  
Nevin Yılmaz
16:20 - 16:40 Immunocompromised Patients 
Bülent Değertekin
16:40 - 17:00 Chronic Renal Failure 
Ebubekir Şenateş
17:00 - 17:20 Co-Infection (HIV and/or HCV)
Tarık Asselah
17:20 - 17:30 Discussion
08:30 - 10:00 LIVER and GUT (Is it really important) 
  Moderators: Ertuğrul Kayaçetin, Mehmet Arhan, Murat  Törüner
08:30 - 08:50 How Important is  Gut Microbiata for NAFLD Development?       
Tarkan Karakan
08:50 - 09:10 Does Non-Response to IBD Treatment Trigger IBD Associated Liver Diseases?    
Murat Törüner                                              
09:10 - 09:30 NASH and  Inflammatory Bowel Diseases: A Bidirectional Relationship From Pathophysiology to Therapy 
Hülya Över Hamzaoğlu
09:30 - 09:50 Importantance of  Gut Microbiata in the Pathogenesis of Liver Cirrhosis
Gerardo Nardone                         
09:50 - 10:00 Discussion
10.00 - 10.30 COFFEE BREAK
10.30 - 12.00 NASH 
  Moderators: Alaaeldin İbrahim, Yusuf Yılmaz, Ahmet Uygun
10:30 - 10:50 Genetics and Epigenetics of NAFLD: From Associations to Understand a Complex Disease 
Müjdat Zeybel
10:50 - 11:10 NAFLD in Obese People        
Metin Başaranoğlu                      
11:10 - 11:30 Differential Diagnosis of NAFLD.   
Salimur Rahman
11:30 - 11:50 New Horizons for the Treatment of NAFLD    
Ian Homer Y. Cua
11:50 - 12:00 Discussion
12.00 - 13:00 Opening Ceremony
13.00 - 14.00 LUNCH
14:00 - 15:30 TOXIC HEPATİTİS 
  Modarators: Şükrü Dumlu, Emin Altıparmak, Murat Taner Gülşen
14:00 - 14:20 Drug Induced Acute Liver Failure   
Fatih Oğuz Önder
14:20 - 14:40 "Autoimmune Like" Drug and Herb Induced Liver Injury    
Joost  Drenth
14:40 - 15:00 Genetic Factors Influencing Drug Induced Liver Injury 
H.Levent Doğanay
15:00 - 15:20 The treatment of Drug Induced Liver Injury
Masood Siddiq
15:20 - 15:30 Discussion
15:30 - 1600 COFFEE BREAK
16.00 - 17.30 CHRONIC HEPATITIS C
  Moderators: Micheal Manns, Gamal Sheha, Mehmet Bektaş
16:00 - 16:20 Primary Antiviral Resistance; Is It Clinically Important?
Tarık Assellah       
16:20 - 16:40 Current Treatment of CHC in Terms of Guide-Lines
Ayşe Aytaman
16:40 - 17:00 Management of Direct Acting Antivirals Treatment Failure
Wasim Jafri
17:00 - 17:20 Management of Acute HCV and Genotype II Infection. When and How ?
Osamu Yokosuka
17:20 - 17:30 Discussion
08:30 - 10:00 HCV
  Moderators: Muhsin Kaya, Erol Avşar,Ömer Topalak
08:30 - 08:50 Is It Necessary to Treat HCV in Patients with Elderly
Mevlüt Başkol
08:50 - 09:10 Is There an Increased Risk for Developping HCC After DAAs Treatment ?
Aydın Şeref Köksal
09:10 - 09:30 Treatment of Non Responders on DAAS for HCV Related Cirrhosis
Lai Wei
09:30 - 09:50 Management of Co-Infection
Özlem Saygılı Yönem
09:50 - 10:00 Discussion
10.00 - 10.30 COFFEE BREAK
10.30 - 12.00 Free Papers
  Moderators: İlyas Tuncer, Hilmi Ataseven, Hakan Dursun
12.00 - 13:00 Opening Ceremony
13.00 - 14.00 LUNCH
14:00 - 15:30   RENAL COMPLICATIONS of LIVER CIRRHOSIS
  Moderators: Orhan Özgür, Mehmet Sökmen, Mehmet Koruk
14:00 - 14:20 Menagement of Hepato Renal Syndrome Type 1 and 2     
Gökhan Kabaçam
14:20 - 14:40 Prescriptions to Prevent Acute Kidney Injury in Patients with Liver Failure
Filiz Akyüz
14:40 - 15:00 Spesific Renal Problems in Hepatitis B and C    
Mustafa Kemal Çelen
15:00 - 15:20 Renal Problems in Patients with Solid Organ Transplanted
Onur Keskin
15:20 - 15:30 Discussion
15:30 - 16:00 COFFEE BREAK
16.00 - 17.30 HCV
  Moderators: Belkıs Ünsal, İsmail Balık, Bilgehan Aygen
16:00 - 16:20 HCV Management in Liver Transplantation Era
Ahmet Gürakar
16:20 - 16:40 The Treatment of HCV in Renal Diseases 
Rosmawati Binti Mohamed 
16:40 - 17:00  The Treatment of HCV in Liver Cirrhosis  
Shahab Abid
17:00 - 17:20 The Treatment of HCV Infection in Hematologic Disorders 
Arif Mansur Coşar
17:20 - 17:30 Discussion
  Endoscopy Workshop (Live Demonstration)
  Director: Hakan Şentürk
Moderator: Wank Lei, A.Kadir Dökmeci, Emrah Alper
08:15 - 10:15 Advanced Techniques in Pancreatic Diagnosis
10:15 - 10:45 COFFEE BREAK
10:45 - 12:45 Difficult Biliary Diagnosis and Stones: Cholangioscopy, Laser Lithotripsy
12:45 - 14:00 LUNCH BREAK
14:00 - 16:00 EUS Guided Gastrointestinal - Biliary, Gastrointestinal - Pancreatic, and Gastro - Intestinal Anastomosis
16:00 - 16:30 COFFEE BREAK
16:30 - 17:30 EUS Guided Vascular Approaches
17:30 - 18:00 Cutting Edge EUS & ERCP: What is on Horizon ?